PKD2 Gene Polycystic Kidney Disease Type 2 Autosomal Dominant Genetic Test
At DNA Labs UAE, we offer the PKD2 Gene Polycystic Kidney Disease Type 2 Autosomal Dominant Genetic Test at a cost of AED 4400.0.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Before undergoing the PKD2 Gene Polycystic Kidney Disease Type 2 Autosomal Dominant Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by PKD2 Gene Polycystic Kidney Disease Type 2 Autosomal Dominant NGS Genetic DNA Test gene PKD2.
Test Details
Polycystic kidney disease type 2 (PKD2) is an autosomal dominant genetic disorder that primarily affects the kidneys. It is caused by mutations in the PKD2 gene, which is responsible for producing a protein called polycystin-2. This protein plays a crucial role in maintaining the structure and function of kidney cells.
Our PKD2 gene NGS genetic test utilizes Next-Generation Sequencing technology to analyze and sequence the DNA of an individual. This advanced method allows for the detection of genetic mutations or variations in multiple genes simultaneously, including the PKD2 gene.
The PKD2 gene NGS genetic test involves obtaining a sample of DNA from the individual, typically through a blood sample or cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the PKD2 gene.
This test can be used for the diagnosis of PKD2 in individuals who exhibit symptoms of the disease or have a family history of PKD2. It can also be utilized for carrier testing in individuals who have a family history of PKD2 but do not display any symptoms themselves.
The results of the PKD2 gene NGS genetic test provide valuable information to healthcare professionals. They can determine the presence or absence of mutations in the PKD2 gene, aiding in the diagnosis, genetic counseling, and treatment decisions.
Test Name | PKD2 Gene Polycystic kidney disease type 2 autosomal dominant Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PKD2 Gene Polycystic kidney disease type 2, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PKD2 Gene Polycystic kidney disease type 2, autosomal dominant NGS Genetic DNA Test gene PKD2 |
Test Details |
Polycystic kidney disease type 2 (PKD2) is an autosomal dominant genetic disorder that affects the kidneys. It is caused by mutations in the PKD2 gene, which is responsible for producing a protein called polycystin-2. This protein plays a crucial role in maintaining the structure and function of kidney cells. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze and sequence the DNA of an individual. It allows for the detection of genetic mutations or variations in multiple genes simultaneously, including the PKD2 gene. A PKD2 gene NGS genetic test involves obtaining a sample of DNA from the individual, usually through a blood sample or cheek swab. The DNA is then sequenced using NGS technology to identify any mutations or variations in the PKD2 gene. This test can be used to diagnose PKD2 in individuals who have symptoms of the disease or a family history of PKD2. It can also be used for carrier testing in individuals who have a family history of PKD2 but do not show any symptoms themselves. The results of the PKD2 gene NGS genetic test can help healthcare professionals determine the presence or absence of mutations in the PKD2 gene, which can aid in diagnosis, genetic counseling, and treatment decisions. |